Home Other Building Blocks 5111-70-6
5111-70-6,MFCD00003789
Catalog No.:AA003MR3

5111-70-6 | 5-Methoxy-1-indanone

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$6.00   $4.00
- +
1g
98%
in stock  
$11.00   $8.00
- +
5g
98%
in stock  
$23.00   $16.00
- +
10g
98%
in stock  
$27.00   $19.00
- +
100g
98%
in stock  
$236.00   $165.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003MR3
Chemical Name:
5-Methoxy-1-indanone
CAS Number:
5111-70-6
Molecular Formula:
C10H10O2
Molecular Weight:
162.1852
MDL Number:
MFCD00003789
SMILES:
COc1ccc2c(c1)CCC2=O
NSC Number:
82964
Properties
Properties
 
BP:
303.6°C at 760 mmHg  
Form:
Solid  
MP:
107-109 °C(lit.)  
Refractive Index:
1.6000 (estimate)  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
188  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
Rotatable Bond Count:
1  
XLogP3:
1.6  

Upstream Synthesis Route

[1]IndianJournalofChemistry,SectionB:OrganicChemistryIncludingMedicinalChemistry,1993,vol.32,#12,p.1209-1213

[2]Patent:US2003/225122,2003,A1,.Locationinpatent:Page18

[3]Patent:US2002/72518,2002,A1,

[4]Patent:US5707994,1998,A,

[5]JournalofMedicinalChemistry,2012,vol.55,#5,p.2452-2468

[6]EuropeanJournalofMedicinalChemistry,2013,vol.69,p.920-930

[1]Patent:US5334600,1994,A,

[2]Patent:US5260316,1993,A,

[1]Patent:US5334600,1994,A,

[1]Patent:CN106278990,2017,A,.Locationinpatent:Paragraph0013;0017;0018;0020;0023;0028

[1]TetrahedronLetters,1998,vol.39,#11,p.1385-1388

[2]Synthesis,1994,#9,p.915-916

[3]JournalofOrganicChemistry,1997,vol.62,#25,p.8767-8772

[4]EuropeanJournalofOrganicChemistry,2003,#3,p.578-586

[5]ChemCatChem,2013,vol.5,#1,p.126-129

Downstream Synthesis Route

[1]CurrentPatentAssignee:LONGXININGSHANGHAIPHARMACEUTICALTECH-CN105884626,2016,ALocationinpatent:Paragraph0075-0077

[2]Pravst,Igor;Zupan,Marko;Stavber,Stojan[TetrahedronLetters,2006,vol.47,#27,p.4707-4710]

[3]Johnson;Anderson;Shelberg[JournaloftheAmericanChemicalSociety,1944,vol.66,p.218,221]

[4]Peglion;Goument;Despaux;Charlot;Giraud;Nisole;Newman-Tancredi;Dekeyne;Bertrand;Genissel;Millan[JournalofMedicinalChemistry,2002,vol.45,#1,p.165-176]

[5]Pravst,Igor;Zupan,Marko;Stavber,Stojan[Tetrahedron,2008,vol.64,#22,p.5191-5199]

[1]CurrentPatentAssignee:AMGENINC-US2006/173183,2006,A1Locationinpatent:Page/Pagecolumn114

[2]Johnson;Shelberg[JournaloftheAmericanChemicalSociety,1945,vol.67,p.1745,1752]

[3]CurrentPatentAssignee:FirmenichInternationalSA-US8148536,2012,B2Locationinpatent:Page/Pagecolumn64

[4]CurrentPatentAssignee:PATHWAYTHERAPEUTICSINC.-WO2012/135166,2012,A1Locationinpatent:Page/Pagecolumn79

[5]CurrentPatentAssignee:ROCHEHOLDINGAG;HARVARDUNIVERSITY-WO2014/145512,2014,A2Locationinpatent:Page/Pagecolumn70;71

[1]MedChemComm,2016,vol.7,p.2418-2427

[2]Patent:US2018/2355,2018,A1.Locationinpatent:Paragraph0095

[3]SyntheticCommunications,2007,vol.37,p.2171-2177

[4]JournaloftheChemicalSociety,1945,p.582,584

[5]MonatsheftefurChemie,1978,vol.109,p.405-419

[6]JournalfurpraktischeChemie(Leipzig1954),1927,vol.<2>115,p.359

[7]JournaloftheChemicalSociety,1923,vol.123,p.1482,1508

[8]Patent:EP897903,1999,A2

[9]MedicinalChemistryResearch,2014,vol.23,p.1340-1349

[1]Noureldin,NazihA.;Zhao,Dongyuan;Lee,DonaldG.[JournalofOrganicChemistry,1997,vol.62,#25,p.8767-8772]

[2]Cambie,RichardC.;Mitchell,LornaH.;Rutledge,PeterS.[AustralianJournalofChemistry,1998,vol.51,#12,p.1167-1174]

[3]Pandey,Ganesh;Laha,Ramkrishna;Singh,Deepak[JournalofOrganicChemistry,2016,vol.81,#16,p.7161-7171]

[4]Tewari,S.C.;Rastogi,ShriNivas;Anand,Nitya[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1980,vol.19,#2,p.139-142]

[5]Lesieur,Mathieu;Genicot,Christophe;Pasau,Patrick[OrganicLetters,2018,vol.20,#7,p.1987-1990]

[6]Johnson;Anderson;Shelberg[JournaloftheAmericanChemicalSociety,1944,vol.66,p.218,221]

[7]Panetta,C.A.;Bunce,S.C.[JournalofOrganicChemistry,1961,vol.26,p.4859-4866]

[8]CurrentPatentAssignee:ABBVIEINC-US2012/40948,2012,A1Locationinpatent:Page/Pagecolumn95-96

[1]CurrentPatentAssignee:TAIWANJPHARMACEUTICALSCOLTD-WO2020/205455,2020,A1Locationinpatent:Paragraph0063;0460-0463

[2]CurrentPatentAssignee:PIRAMALENTERPRISESLIMITED-WO2015/28960,2015,A1Locationinpatent:Page/Pagecolumn130;131

[3]Sam;Snapp[JournalofPharmaceuticalSciences,1965,vol.54,#5,p.756-760]

[4]Hofer,O.[MonatsheftefurChemie,1978,vol.109,p.405-419]Friedrich,EdwinC.;Tam,TeresaM.[JournalofOrganicChemistry,1982,vol.47,#2,p.315-319]

[5]Fournier;Berthelot;Pavard;etal.[EuropeanJournalofMedicinalChemistry,1981,vol.16,#1,p.48-58]

[6]Sampson,Kyere;Paik,Augustine;Duvall,Bridget;Whalen,DaleL.[JournalofOrganicChemistry,2004,vol.69,#16,p.5204-5211]

[7]Ulmschneider,Sarah;Müller-Vieira,Ursula;Klein,ChristianD.;Antes,Iris;Lengauer,Thomas;Hartmann,RolfW.[JournalofMedicinalChemistry,2005,vol.48,#5,p.1563-1575]

[8]CurrentPatentAssignee:ABBVIEINC-US2012/40948,2012,A1Locationinpatent:Page/Pagecolumn96-97

[9]Yoshimatsu,Shuhei;Yamada,Akira;Nakata,Kenya[JournalofOrganicChemistry,2018,vol.83,#1,p.452-458]

[10]Gui,Jiao;Xie,Haisheng;Chen,Fengjuan;Liu,Zhipeng;Zhang,Xiaoqi;Jiang,Fubin;Zeng,Wei[OrganicandBiomolecularChemistry,2020,vol.18,#5,p.956-963]

Literature

Title: Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.

Journal: Anti-cancer drugs 20090101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:5111-70-6 Molecular Formula|5111-70-6 MDL|5111-70-6 SMILES|5111-70-6 5-Methoxy-1-indanone |Organic_Building_Blocks